In biopharma, the next edge may come from the systems that turn discovery into scale.
Innovation alone is no longer enough in biopharma
Innovation alone is no longer enough in biopharma is a pharma and life sciences industry update from BioPharma Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: BioPharma Dive